Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13304-13312
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Figure 2 Comparison of progression-free and overall survival in patients with different serum Spondin-2 expression levels.
A: Progression-free survival; B: Overall survival. PFS: Progression-free survival; OS: Overall survival.
- Citation: Zhang LL, Lin S, Zhang Y, Yao DM, Du X. Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer. World J Clin Cases 2022; 10(36): 13304-13312
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13304.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13304